- Paradigm Biopharmaceuticals Ltd at NWR Healthcare Conference (Virtual) TranscriptMar 22, 2023
- Paradigm Biopharmaceuticals Ltd Annual Shareholders Meeting TranscriptNov 29, 2022
- Paradigm Biopharmaceuticals Ltd Investor Webinar TranscriptOct 04, 2022
- Paradigm Biopharmaceuticals Ltd Investor Webinar TranscriptAug 15, 2022
- Paradigm Biopharmaceuticals Ltd Investor Webinar TranscriptJul 21, 2022
- Paradigm Biopharmaceuticals Ltd at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Paradigm Biopharmaceuticals Ltd Corporate Call TranscriptAug 05, 2021
- Paradigm Biopharmaceuticals Ltd at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Paradigm Biopharmaceuticals Ltd Inaugural R&D Day TranscriptDec 21, 2020
- Paradigm Biopharmaceuticals Ltd Investor Call (Virtual) TranscriptApr 08, 2020
- Paradigm Biopharmaceuticals Ltd at NWR Communications Virtual Small Cap Investor Conference TranscriptMar 26, 2020
Paradigm Biopharmaceuticals Ltd Inaugural R&D Day Transcript
Good morning and welcome to Paradigm's R&D Day. My name is Paul Rennie. I'm Founder and Chief Executive Officer of Paradigm Biopharmaceuticals. I'd like to extend a special welcome to the people joining us from Hong Kong and Singapore, and also people from the United States of America where it is Sunday afternoon or Sunday evening in the US.
Next slide, please. As Paradigm is an ASX-listed company, we are required to provide a disclaimer in regards to forward-looking statements. And in particular, this is a presentation around the timelines and our expectations of clinical trials. And as we all know, they are subject to change particularly within the context of a global pandemic. However, this is our best estimate of our timelines as of today. And any changes will, of course, be communicated to the market with regular ASX updates.
Next slide, please. So I'd like to start with the objectives of Paradigm's R&D Day. Paradigm's R&D Day is a forum to provide you with a deep insight into Paradigm's research programs
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)